Howard Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Buy
5,901
+5,010
+562% +$1.86M 0.03% 176
2026
Q1
$261K Sell
891
-3,836
-81% -$1.26M ﹤0.01% 291
2025
Q4
$1.66M Buy
4,727
+2,664
+129% +$900K 0.02% 179
2025
Q3
$667K Buy
2,063
+404
+24% +$126K 0.01% 260
2025
Q2
$645K Buy
1,659
+341
+26% +$137K 0.01% 263
2025
Q1
$573K Sell
1,318
-206
-14% -$82.7K 0.01% 250
2024
Q4
$562K Buy
1,524
+72
+5% +$30.1K 0.01% 275
2024
Q3
$755K Buy
+1,452
New +$776K 0.01% 237

Other funds holding ELV

Howard Capital Management's ELV Position: Q2 2026 in Review

Howard Capital Management increased its Elevance Health (ELV) stake by 562% in Q2 2026, buying an estimated $1.86M and bringing the position to 5,901 shares worth $2.28M. The position accounts for 0.03% of the portfolio, ranked #176.

Howard Capital Management first reported a position in ELV in Q3 2024 and has held it in 8 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Howard Capital Management held 5,901 shares of Elevance Health worth $2.28M as of Q2 2026.
  • Howard Capital Management bought 5,010 Elevance Health shares in Q2 2026, an estimated $1.86M.
  • Elevance Health made up 0.03% of Howard Capital Management's portfolio in Q2 2026, its #176 holding.
  • Howard Capital Management first reported a position in Elevance Health in Q3 2024 and has held it in 8 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.